Basic Information
ID: ALA711378
Type: Functional
Description: Antiviral potency evaluated by measuring accumulation of viral RNA transcripts 3 days after infection of MT-2 cells with HIV-1 RF
Format: BAO_0000219
Organism: Homo sapiens
Cell type: MT2
Target: MT2(ALA614184)
Document: ALA1131003
Antiviral potency evaluated by measuring accumulation of viral RNA transcripts 3 days after infection of MT-2 cells with HIV-1 RF: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA711378
IC90
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 824.94 | 7.33 | 7.33 |
| 566.70 | 4.05 | 4.05 |
| 606.77 | 7.38 | 7.38 |
| 576.70 | 4.30 | 4.30 |
| 606.73 | 4.50 | 4.50 |
| 570.70 | 5.85 | 5.85 |
| 758.93 | 6.49 | 6.49 |
| 724.82 | 5.02 | 5.02 |
| 593.70 | 5.13 | 5.13 |
| 575.71 | 4.99 | 4.99 |
| 589.74 | 5.01 | 5.01 |
| 588.71 | 5.15 | 5.15 |
| 680.81 | 5.90 | 5.90 |
| 628.74 | 4.11 | 4.11 |
| 628.74 | 4.11 | 4.11 |
| 627.75 | 4.71 | 4.71 |
| 592.70 | 3.27 | 3.27 |
| 746.87 | 6.36 | 6.36 |
| 691.84 | 6.43 | 6.43 |
| 655.76 | 4.42 | 4.42 |
| 655.76 | 4.42 | 4.42 |
| 561.69 | 4.53 | 4.53 |
| 654.77 | 5.02 | 5.02 |
| 670.84 | 6.43 | 6.43 |
| 590.72 | 4.48 | 4.48 |
| 562.67 | 4.65 | 4.65 |
| 590.68 | 4.64 | 4.64 |
| 627.75 | 4.92 | 4.92 |
| 575.71 | 4.84 | 4.84 |
| 579.68 | 4.67 | 4.67 |
| 579.68 | 4.67 | 4.67 |
| 665.79 | 5.77 | 5.77 |
| 626.76 | 5.19 | 5.19 |
| 561.69 | 4.53 | 4.53 |
| 672.81 | 5.65 | 5.65 |
| 680.81 | 5.90 | 5.90 |
| 607.69 | 4.18 | 4.18 |
| 666.78 | 5.59 | 5.59 |
| 627.75 | 4.58 | 4.58 |
| 627.75 | 4.58 | 4.58 |
| 627.75 | 4.58 | 4.58 |
| 586.70 | 4.82 | 4.82 |
| 613.72 | 4.73 | 4.73 |
| 708.89 | 7.17 | 7.17 |
| 709.83 | 6.57 | 6.57 |
| 648.80 | 4.57 | 4.57 |
| 620.75 | 3.79 | 3.79 |
| 655.76 | 4.42 | 4.42 |
| 622.73 | 3.47 | 3.47 |
| 628.74 | 4.11 | 4.11 |
| 618.73 | 4.66 | 4.66 |
| 456.55 | 3.03 | 3.03 |
| 536.68 | 4.23 | 4.23 |